The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...
Every year, somewhere between 19 and 21 million Americans come down with gastroenteritis (aka “stomach flu”), most often caused by a group of pathogens called noroviruses. These infections ...
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
In other parts of the world, Moderna's vaccine shares the same principle. COVID-19 vaccines used in Brazil are from three different technology platforms.
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...
Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...
Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.